Perry M. Elliott
Barts Heart Centre St Bartholomew's Hospital
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 417 publications
Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
Journal: The New England journal of medicine
Published: August 28, 2026
Damaging RBM20 E-rich domain variants are not rescued by gene replacement.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2026
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.
Journal: JAMA cardiology
Published: June 17, 2026
The Threshold for a Clinically Meaningful Improvement in Cardiopulmonary Exercise Testing Measures for Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Journal: Journal of cardiac failure
Published: June 10, 2026
Efficacy of Aficamten vs Metoprolol According to Pretrial Beta-Blocker Treatment in Obstructive Hypertrophic Cardiomyopathy: Insights From MAPLE-HCM.
Journal: JACC. Heart failure
Published: June 08, 2026
Hypertrophic cardiomyopathy: a genome-wide association meta-analysis and polygenic risk score.
Journal: Journal of medical genetics
Published: May 13, 2026
Yield of Postmortem Genetic Testing in Sudden Arrhythmic Death Syndrome: A Systematic Review and Meta-Analysis.
Journal: Circulation. Genomic and precision medicine
Published: April 14, 2026
RBM20 Truncating Variants and Human Cardiomyopathy.
Journal: JAMA cardiology
Published: April 08, 2026
Last Updated: 09/26/2026